• Home
  • Our Team
  • Careers
  • Media Center
    • MEDIcept Insights
    • White Papers
      • Company News
      • Press Inquiries
  • Contact Us
  • Call: 508-231-8842
MEDIcept Logo with Trusted Solutions tagline
  • Quality
  • Regulatory
  • Clinical
  • Engineering
  • Reimbursement
MEDIcept Logo with Trusted Solutions tagline
  • 508-231-8842
  • Home
  • Our Team
  • Quality
  • Regulatory
  • Clinical
  • Engineering
  • Reimbursement
  • Media Center
    • MEDIcept Insights
    • White Papers
      • Company News
      • Press Inquiries
  • Contact Us

Part 3 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December

Dec 12, 2022 | News

Part 3 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December In Part 2 of this series, we discussed FDA’s first proposed rule, “Protection of Human Subjects and Institutional...

Part 2 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA regulations with the Common Rule – Comment Period Extended until December

Dec 5, 2022 | News

In Part 1 of this series, we discussed the basic summary of FDA’s two proposed rules involving human subject protections and IRBs, as well as the extension FDA made to allow for commenters to have more time to develop thoughtful responses to the proposed rules. Part 2...

Part 1 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December

Nov 29, 2022 | News

On September 28, 2022, FDA released two proposed rules aimed at amending some sections of its current regulations on human subject protections and Institutional Review Boards (IRBs) with the revised Federal Policy for the Protection of Human Subjects—also known as the...

Latest Content

  • The Future of Clinical Trials: Decentralized Trial Considerations January 30, 2023
  • Revolutionizing Healthcare: The Emergence of Al-Powered Medical Devices January 25, 2023
  • VALID Act Fails to Pass – What to Expect for the Future of LDT Regulation January 23, 2023

Popular Tags

Clinical Clinical Trials Combination Products Compliance Documents Engineering FDA Guidance Documents Medical Device Post-Market Quality Systems Regulation Regulatory

Contact Us

MEDIcept

Main Office

200 Homer Ave
Ashland, MA 01721

508-231-8842

Contact Us

Directions

Join Our Team

  • Follow
  • Follow

© 2022 Medicept | Website Designed and Developed by inConcert Web Solutions | Site Map